Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
about
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASHPathophysiological role of host microbiota in the development of obesityThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseKupffer cells in the liverMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.Toll-like receptors in secondary obstructive cholangiopathy.Toll-like receptors in liver fibrosis: cellular crosstalk and mechanismsAnimal Models Correlating Immune Cells for the Development of NAFLD/NASH.Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: composition mattersToll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in miceConcomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.Carvacrol Protects against Hepatic Steatosis in Mice Fed a High-Fat Diet by Enhancing SIRT1-AMPK Signaling.Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease.Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis.Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease.Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.Pathophysiology of NASH: perspectives for a targeted treatment.Regulation of wound healing and organ fibrosis by toll-like receptors.Immune and inflammatory pathways in NASH.Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools.Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunologyRole of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis.CD18 deficiency improves liver injury in the MCD model of steatohepatitis.Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice.Dietary fat source alters hepatic gene expression profile and determines the type of liver pathology in rats overfed via total enteral nutrition.Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury.Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease.
P2860
Q26742102-9F91C026-F820-4894-9CB9-59FE9D22F19FQ26750893-B36F45CE-0B33-4E9A-9407-E16261F7F3ECQ26780509-E3247447-38A8-4AAA-B5DF-B22D1C07EE16Q26822031-F263453F-9CDB-4A5F-AF74-735BD9976180Q27007515-7B3403C8-A54C-4E16-BC01-280E0DD15DF6Q33755566-1E80C053-291A-4D42-9DB6-06DAD5E58A89Q33780172-22A15036-EEB4-435F-8F7B-BE006D1D4D9FQ34641213-26F10FC7-1BEB-4297-8DE6-764D37965F52Q34750494-6EAA06C4-CD47-446B-A50F-ED9E8FCEEECEQ35495496-11FA5556-8560-495C-BE40-8B908299CF56Q35977675-758F747A-6AC9-4782-B3C4-6B0805F4130DQ36245960-7436A016-4DB8-484A-994C-C4304D9EADB0Q36462046-ECE1D86F-3B54-4A79-BDD6-FF6CF916AFC9Q36592306-B56096AA-C84F-4DD7-AE27-B1F3ACD6AE7FQ36638114-C6D03BFE-8A2B-4BBD-A06E-E5E8DFC50D8BQ36663142-5417A008-11AC-42D5-95F6-6D3DC4558FE2Q36941050-C4602217-D50F-48C4-9336-AC24B620A5CAQ36986160-2527614F-CEFE-4E91-B056-B50254045CBEQ37311913-C44D1A6E-83B8-4A75-A275-B89BC55B6FA4Q37411483-F148F782-6FFE-4415-B6B5-35F15CCF8F03Q37465565-FA5B2000-4B77-45C7-877D-3F0D2FFD9B03Q37699476-F729EF77-F95D-4300-A162-61724E3541FDQ38065649-4E1715C1-F2A0-4E92-8D37-0DC12FB8FD59Q38192633-28DC2905-46CD-4101-ADDF-98A1F92DE97FQ38209324-ECEB1B3F-D2DF-41DE-9EF7-F561BA01104AQ38311151-62CA93A7-207B-4B77-A955-C98DD4C0DFD4Q39038603-908ACDFD-2ED4-4AAC-B233-97ED647EE43BQ41617791-69BB030D-1FA7-4D72-894B-B202A23664B2Q53099275-A3EA0950-4C4F-4A8D-9EAD-DEB249F46C57Q54291501-EF519A7E-53C5-4B92-9111-FE82272DB5EBQ54402929-3AF9B38A-7B52-478B-9E88-08EA4AB6A5F2Q55008998-E0754D4B-6595-42F1-A956-13C46D1D42FD
P2860
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
@ast
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
@en
type
label
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
@ast
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
@en
prefLabel
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
@ast
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
@en
P2093
P2860
P356
P1433
P1476
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
@en
P2093
Chantal A Rivera
Kevin Pruitt
Kristen Brady
LaTausha Gaskin
Monique Allman
Patrick Adegboyega
P2860
P2888
P356
10.1186/1471-230X-10-52
P577
2010-05-28T00:00:00Z
P6179
1021216603